S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q1 2023

RA Capital Management

Period: Q1 2023 Β· Filed: 2023-05-15
View on SEC EDGAR β†—
AUM
$4.42B
Total portfolio value
Positions
59
Reported securities
Top Holding
ASND
16.9% $746.0M
QoQ Changes
+4 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$746.0M16.89%$107.22$274.50+156.0%
16.9%
PCVXVAXCYTE INC$273.3M6.19%$37.48$58.39+55.8%
6.2%
DICEDICE THERAPEUTICS INC$225.1M5.10%β€”β€”
5.1%
ETNB89BIO INC$173.9M3.94%β€”β€”
3.9%
AVTEAEROVATE THERAPEUTICS INC$166.7M3.77%β€”β€”
3.8%
BIIBBIOGEN INC$148.2M3.35%$278.03$216.12-22.3%
3.4%
VRNAVERONA PHARMA PLC$126.9M2.87%β€”β€”
2.9%
CTKBCYTEK BIOSCIENCES INC$123.0M2.78%$9.19$4.59-50.0%
2.8%
VORXXXXVOR BIOPHARMA INC$122.4M2.77%β€”β€”
2.8%
LEGNLEGEND BIOTECH CORP$117.5M2.66%$48.22$29.91-38.0%
2.7%
TYRATYRA BIOSCIENCES INC$116.3M2.63%$16.07$30.62+90.5%
2.6%
JANXJANUX THERAPEUTICS INC$104.9M2.38%$12.10$15.54+28.4%
2.4%
PEPGPEPGEN INC$99.5M2.25%$12.23$1.76-85.6%
2.3%
RNAMAVIDITY BIOSCIENCES INC$98.5M2.23%β€”β€”
2.2%
RYTMRHYTHM PHARMACEUTICALS INC$98.4M2.23%$17.84$114.17+540.0%
2.2%
DAWNDAY ONE BIOPHARMACEUTICALS I$94.1M2.13%β€”β€”
2.1%
BLUBELLUS HEALTH INC NEW$91.0M2.06%β€”β€”
2.1%
CVACCUREVAC N V$85.3M1.93%β€”β€”
1.9%
IMGNIMMUNOGEN INC$83.9M1.90%β€”β€”
1.9%
WVEWAVE LIFE SCIENCES LTD$74.5M1.69%$4.33$6.26+44.6%
1.7%
INBXINHIBRX INC$72.7M1.65%β€”$97.58
1.6%
GERNGERON CORP$68.5M1.55%$2.17$1.36-37.3%
1.6%
COGTCOGENT COMMUNICATIONS HLDGS$64.7M1.47%$10.79$38.69+258.6%
1.5%
CLDXCELLDEX THERAPEUTICS INC NEW$62.4M1.41%$35.98$38.37+6.6%
1.4%
ACRVACRIVON THERAPEUTICS INC$61.0M1.38%$12.69$1.72-86.5%
1.4%
ITOSITEOS THERAPEUTICS INC$60.1M1.36%β€”β€”
1.4%
NAMSNEWAMSTERDAM PHARMA COMPANY$53.0M1.20%$13.26$34.83+162.7%
1.2%
VRDNVIRIDIAN THERAPEUTICS INC$51.1M1.16%$25.44$19.40-23.7%
1.2%
RXSTRXSIGHT INC$50.9M1.15%$16.68$5.61-66.4%
1.1%
MLYSMINERALYS THERAPEUTICS INC$49.8M1.13%$15.66$27.69+76.8%
1.1%

Quarter-on-Quarter Activity

Q1 2023 vs. Q4 2022

New Positions (4)

TickerIssuerNotionalSince Filing
CVACCUREVAC N V$85.3M
MLYSMINERALYS THERAPEUTICS INC$49.8M+76.8%
PLRXPLIANT THERAPEUTICS INC$46.9M
ELVNENLIVEN THERAPEUTICS INC$46.5M

Exited Positions (8)

TickerIssuerNotional
TVTXTRAVERE THERAPEUTICS INC$83.8M
AKROAKERO THERAPEUTICS INC$52.5M
DALSDA32 LIFE SCNCE$15.0M
SCPHSCPHARMACEUTICALS INC$13.3M
IMRAIMARA INC$13.3M
ARYEARYA SCIENCES ACQUISITN CORP$10.1M
CNCECONCERT PHARMACEUTICALS INC$6.4M
HSAQHEALTH SCIENCES ACQ CORP 2$6.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
NSTGQNANOSTRING TECHNOLOGIES$23.2M+1607.6%
GERNGERON CORP$37.2M+144.0%-37.3%
VRDNVIRIDIAN THERAPEUTICS INC$25.4M+128.2%-23.7%
HOWLWEREWOLF THERAPEUTICS INC$7.2M+43.2%
ETNB89BIO INC$59.9M+27.5%
PCVXVAXCYTE INC$-7.6M+24.5%+55.8%
FULCFULCRUM THERAPEUTICS INC$-36.1M+22.1%
RNAMAVIDITY BIOSCIENCES INC$-22.5M+17.6%

Trimmed (2)

TickerIssuerNotionalShares Ξ”Since Filing
RCKTROCKET PHARMACEUTICALS INC$-27.7M-53.0%
CLDXCELLDEX THERAPEUTICS INC NEW$-30.1M-16.4%+6.6%
← Back to Hedge Funds